Pascal Jézéquel
The Lancet Oncology · 2012–2015
A researcher in the Science corpus: 2 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Whom Pascal Jézéquel trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Pascal Jézéquel overall
Papers from Pascal Jézéquel's perspective
Ordered by how strongly the researchers Pascal Jézéquel trusts endorse each paper. Same corpus, a different order for every researcher.
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repository (Nucleic Acids Res.)
- Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes (Clinical Cancer Research)
- Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. (Journal of Clinical Oncology)
- The Nottingham prognostic index in primary breast cancer (Breast Cancer Research and Treatment)
- Molecular classification and molecular forecasting of breast cancer: ready for clinical application? (Journal of Clinical Oncology)
- Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. (Journal of Clinical Oncology)
- ArrayExpress update—from an archive of functional genomics experiments to the atlas of gene expression (Nucleic Acids Res.)
- A Coefficient of Agreement for Nominal Scales
- Controlling the false discovery rate: a practical and powerful approach to multiple testing
- Molecular portraits of human breast tumours (Nature)
Their papers
- Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. (2015) — 959 citations
- bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer (2012) — 362 citations